Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Clinical Pharmacokinetics|October 1, 1987
Clinical pharmacokinetics of some newer diureticsB Beermann, M GrindJournal of Internal Medicine|June 6, 2007
Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillationG Y H Lip, L Frison, M GrindJournal of Internal Medicine|February 13, 2008
Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillationG Y H Lip, L Frison, M Grind, et al.Clinical Pharmacology and Therapeutics|October 1, 1993
Method for studying drug-warfarin interactionsM Grind, M Murphy, S Warrington, et al.Clinical Pharmacology and Therapeutics|October 1, 1984
Relationship of N-demethylation of amiflamine and its metabolite to debrisoquine hydroxylation polymorphismG Alván, M Grind, C Graffner, et al.Acta Pharmacologica Et Toxicologica|August 1, 1986
Pharmacokinetics of zimeldine in male alcoholicsC G Gottfries, M Grind, J Lundström, et al.European Journal of Clinical Pharmacology|January 1, 1997
Bioequivalence, pharmacokinetic and pharmacodynamic response to combined extended release formulations of felodipine and metoprolol in healthy volunteersJ Aberg, B Abrahamsson, M Grind, et al.Psychopharmacology|January 1, 1988
Remoxipride--a new potential antipsychotic drug. Pharmacological effects and pharmacokinetics following repeated oral administration in male volunteersL Farde, M Grind, M I Nilsson, et al.Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Drug interaction studies with remoxiprideW Yisak, C von Bahr, L Farde, et al.Psychopharmacology|January 1, 1989
Remoxipride--a new potential antipsychotic compound. Tolerability and pharmacokinetics after single oral and intravenous administration in healthy male volunteersM Grind, M I Nilsson, L Nilsson, et al.Pageof 2